跳至主要内容
临床试验/ACTRN12611000082909
ACTRN12611000082909撤回4 期

A double blind randomised controlled trial assessing the effect of zoledronate on marrow fat in older osteoporotic persons after suffering a minimal trauma fracture

SWAHS - Clinical Governance Office0 个研究点目标入组 60 人开始时间: 2011年1月21日最近更新:
适应症

试验速览

阶段
4 期
状态
撤回
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
65 Years 至 100 Years(—)
性别
Female

入选标准

  • 1- History of minimal trauma fracture within 90 days before starting the trial
  • 2- Age: Older than 65

排除标准

  • 1) Patients taking statins for cholesterol lowering
  • 2) Previous history of diabetes mellitus
  • 3)creatinine clearance < 35 ml/min
  • 4)pre-existing hypocalcemia must be treated by adequate intake of calcium and vitamin D before therapy with zoledronic acid
  • 5)active history of uveitis, iritis, or episcleritis
  • 6)metastatic cancer or cancer diagnosed less than 2 years ago where treatment is still ongoing
  • 7)Active primary hyperparathyroidism
  • 8)Hypothyroidism, not appropriately controlled with long-term thyroxine therapy
  • 9)Serum 25-hydroxyvitamin D concentrations <15 ng/

研究者

发起方
SWAHS - Clinical Governance Office

相似试验